下载掌阅APP，畅读海量书库
立即打开
［1］CHOI S Y, SUH K S, CHOI D E, et al. Morphometric analysis of podocyte foot process effacement in IgA nephropathy and its association with proteinuria [J]. Ultrastruct Pathol, 2010, 34 (4): 195-198.
［2］LAI K N, LEUNG J C, CHAN L Y, et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy [J]. Nephrol Dial Transplant, 2009, 24 (1): 62-72.
［3］GAGLIARDINI E, BENIGNI A, TOMASONI S, et al. Targeted downregulation of extracellular nephrin in human IgA nephropathy [J]. Am J Nephrol, 2003, 23 (4): 277-286.
［4］FUKUDA A, SATO Y, IWAKIRI T, et al. Urine podocyte mRNAs mark disease activity in IgA nephropathy [J]. Nephrol Dial Transplant, 2015, 30 (7): 1140-1150.
［5］HARA M, YANAGLIHARA T, KIHARA I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis [J]. Clin J Am Soc Nephrol, 2007, 2 (2): 231-238.
［6］ROBERTS I S, COOK H T, TROYANOV S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility [J]. Kidney Int, 2009, 76 (5): 546-556.
［7］EL K K, HILL G S, KARRAS A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies [J]. Kidney Int, 2011, 79 (6): 643-654.
［8］COPPO R, TROYANOV S, BELLUR S, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments [J]. Kidney Int, 2014, 86 (4): 828-836.
［9］COOK H T. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury [J]. Kidney Int, 2011, 79 (6): 581-583.
［10］HILL G S, KAROUI K E, KARRAS A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies [J]. Kidney Int, 2011, 79 (6): 635-642.
［11］ASAO R, ASANUMA K, KODAMA F, et al. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy [J]. Clin J Am Soc Nephrol, 2012, 7 (9): 1385-1393.
［12］BELLUR S S, LEPEYTRE F, VOROBYEVA O, et al. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy [J]. Kidney Int, 2017, 91 (1): 235-243.
［13］TRIMARCHI H, BARRATT J, CATTRAN D C, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group [J]. Kidney Int, 2017, 91 (5): 1014-1021.
［14］SEKI T, ASANUMA K, ASAO R, et al. Significance of urinary full-length megalin in patients with IgA nephropathy [J]. PLoS One, 2014, 9 (12): e114400.
［15］MENON M C, CHUANG P Y, HE J C. Role of podocyte injury in IgA nephropathy [J]. Contrib Nephrol, 2013, 181: 41-51.
［16］WANG C, LIU X, KE Z, et al. Mesangial medium from IgA nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Akt signaling pathway [J]. Cell Physiol Biochem, 2012. 29 (5-6): 743-752.
［17］ASANUMA K, AKIBA K M, KODAMA F, et al. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy [J]. Am J Nephrol, 2011, 33 (6): 537-549.
［18］KODAMA F, ASANUMA K, TAKAGI M, et al. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy [J]. Nephrol Dial Transplant, 2013, 28 (7): 1762-1772.
［19］KANG Y S, LI Y, DAI C, et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria [J]. Kidney Int, 2010, 78 (4): 363-373.